Benzquinamide

CAS : 63-12-7

Ref. 3D-AAA06312

Informations sur le produit

• Nom: Benzquinamide
• Synonymes: 2-(Acetyloxy)-N,N-diethyl-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-2H-benzo[a]quinolizine-3-carboxamide, 2-Hydroxy-3-diethylcarbamoyl-9,10-dimethoxy-1,2,3,4,6,7-hexahydro-11b,4-benzoquinolizine acetate, 2-Hydroxy-3-diethylcarbamyl-9,10-dimethoxy-1,2,3,4,6,7-hexahydro-11bH-benzoquinolizine acetate, 2H-Benzo[a]quinolizine-3-carboxamide, N,N-diethyl-1,3,4,6,7,11b-hexahydro-2-hydroxy-9,10-dimethoxy-, acetate (ester), BZQ, Benzoquinamide, Emete-Con, Emeticon, N,N-Diethyl-1,3,4,6,7,11b-hexahydro-2-hydroxy-9,10-dimethoxy-2H-benzo[a]quinolizine-3-carboxamide acetate, Nsc 64375, P 2647, Promecon
• CAS: 63-12-7

Description

Benzquinamide is a drug used in the treatment of cardiac conditions. It has been shown to significantly reduce the frequency and severity of symptoms in patients with schizophrenia. Benzquinamide also has a diuretic effect, which is due to its ability to inhibit dopamine reuptake. This drug is excreted mainly through the kidney and can be detected in urine samples. The use of benzquinamide for cardiac conditions may lead to an increased risk of cancer, but this link has not been confirmed. The use of benzquinamide may have an adverse effect on wastewater treatment processes due to its ability to inhibit dopamine reuptake. Benzquinamide is classified as a Class C drug in Australia, meaning it should only be used when other treatments are ineffective or not tolerated by the patient.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 404.5 g/mol
• Formule: C₂₂H₃₂N₂O₅
• Degré de pureté: Min. 95%